Eisai
4523.T
#1947
Rank
C$12.27 B
Marketcap
$43.53
Share price
0.09%
Change (1 day)
-31.76%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.16. In 2022 the company made an earnings per share (EPS) of $2.32 a decrease over its 2021 EPS that were of $10.31.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9526.93%
2022$2.32-77.48%
2021$10.31-41.88%
2020$17.74-0.94%
2019$17.9152.59%
2018$11.74124.17%
2017$5.24-49.42%
2016$10.3537.08%
2015$7.55-11.75%
2014$8.56-3.23%
2013$8.84-18.56%
2012$10.86-15.51%
2011$12.85-3.75%
2010$13.36-1.36%
2009$13.54